Moreover, collective analysis of CREB-CRTC2 function in peripheral tissues suggests that chronic activation of this pathway contributes to pathological changes associated with insulin resistance, including hyperglycemia, hyperinsulinemia, and adipose tissue inflammation52–55. The gene discussed is CREB1; the disease is Hyperinsulinemia.